# Prospective Multi-Center Randomized Study for Evaluating the EVAHEART®2 Left Ventricular Assist System

> **NCT01187368** · NA · SUSPENDED · sponsor: **Evaheart, Inc.** · enrollment: 399 (estimated)

## Conditions studied

- Heart Failure

## Interventions

- **DEVICE:** EVAHEART Left Ventricular Assist System (LVAS)
- **DEVICE:** HeartMate 3

## Key facts

- **NCT ID:** NCT01187368
- **Lead sponsor:** Evaheart, Inc.
- **Sponsor class:** INDUSTRY
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** SUSPENDED
- **Start date:** 2020-03-31
- **Primary completion:** 2027-07-31
- **Final completion:** 2028-07-31
- **Target enrollment:** 399 (ESTIMATED)
- **Why stopped:** Subject recruitment is temporarily on hold due to ongoing device modification.
- **Last updated:** 2026-03-27


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01187368

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01187368, "Prospective Multi-Center Randomized Study for Evaluating the EVAHEART®2 Left Ventricular Assist System". Retrieved via AI Analytics 2026-06-01 from https://api.ai-analytics.org/clinical/NCT01187368. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*